RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 56 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $258,000 | -44.5% | 46,907 | -2.3% | 0.00% | -100.0% |
| Q4 2021 | $465,000 | -55.7% | 48,021 | -18.2% | 0.00% | 0.0% |
| Q3 2021 | $1,049,000 | -24.6% | 58,683 | +2.9% | 0.00% | -50.0% |
| Q2 2021 | $1,392,000 | -21.4% | 57,031 | -14.7% | 0.00% | 0.0% |
| Q1 2021 | $1,771,000 | +293.6% | 66,841 | +12.8% | 0.00% | +100.0% |
| Q4 2020 | $450,000 | +76.5% | 59,256 | +16.2% | 0.00% | – |
| Q3 2020 | $255,000 | -26.9% | 50,983 | -12.6% | 0.00% | -100.0% |
| Q2 2020 | $349,000 | +72.8% | 58,348 | +28.4% | 0.00% | – |
| Q1 2020 | $202,000 | -53.1% | 45,455 | +0.2% | 0.00% | -100.0% |
| Q4 2019 | $431,000 | +21.8% | 45,362 | +0.7% | 0.00% | 0.0% |
| Q3 2019 | $354,000 | -50.3% | 45,058 | -0.5% | 0.00% | 0.0% |
| Q2 2019 | $712,000 | -6.4% | 45,273 | +7.6% | 0.00% | 0.0% |
| Q1 2019 | $761,000 | +189.4% | 42,065 | +157.6% | 0.00% | 0.0% |
| Q4 2018 | $263,000 | +27.1% | 16,329 | +89.5% | 0.00% | – |
| Q3 2018 | $207,000 | – | 8,618 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 38,506,526 | $6,546,109 | 0.21% |
| HARBOURVEST PARTNERS LLC | 986,878 | $172,704 | 0.06% |
| Artal Group S.A. | 2,042,666 | $357 | 0.02% |
| Virtu Financial LLC | 68,825 | $12 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 1,277,196 | $222 | 0.00% |
| STATE OF MICHIGAN RETIREMENT SYSTEM | 640,000 | $110,144 | 0.00% |
| Baillie Gifford | 4,869,126 | $837,977 | 0.00% |
| Citadel Advisors | 600 | $103 | 0.00% |
| Tower Research Capital LLC (TRC) | 25 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 2,196 | $0 | 0.00% |